Overview

Food Effect and CYP1A2 Induction Study in Healthy Subjects

Status:
Completed
Trial end date:
2014-09-19
Target enrollment:
Participant gender:
Summary
This study will evaluate the effect of food and smoking on healthy older subjects taking pomalidomide.
Phase:
Phase 1
Details
Lead Sponsor:
Celgene
Celgene Corporation
Treatments:
Caffeine
Pomalidomide
Thalidomide